In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.
AUTOR(ES)
Verbist, L
RESUMO
The new in vitro activity of temocillin (BRL 17421), a new beta-lactamase-stable penicillin, was compared with those of other beta-lactam antibiotics for over 500 clinical bacterial isolates. Temocillin inhibited 94% of the Enterobacteriaceae organisms at concentrations of 0.5 to 8 microgram/ml, regardless of organisms resistance to ampicillin, ticarcillin, cefazolin, or combinations thereof. Most pseudomonas aeruginosa isolates and all staphylococci and streptococci tested were resistant to temocillin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183693Documentos Relacionados
- Comparative in vitro study of temocillin (BRL 17421), a new penicillin.
- In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic.
- In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria.
- Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
- In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
